Trial Profile
Treximet in the Treatment of Chronic Migraine.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Naproxen sodium/sumatriptan (Primary) ; Naproxen
- Indications Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- 01 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Sep 2011 Additional trial centre (Texas Headache Associates) identified as reported by ClinicalTrials.gov.